Feasibility of Using Hyperosmolar Mannitol as a Liquid Tumor Embolization Agent

References

1. ↵
   Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 2002;359:1734–1739

   CrossRefPubMedWeb of Science
2. ↵
   Camma C, Schepis F, Orlando A, et al. Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 2002;224:47–54

   PubMedWeb of Science
3. ↵
   Gruber A, Killer M, Mazal P, et al. Preoperative embolization of intracranial meningiomas: a 17-year single center experience. Minim Invasive Neurosurg 2000;43:18–29

   CrossRefPubMed
4. Latchaw RE. Preoperative intracranial meningioma embolization: technical considerations affecting the risk-to-benefit ratio. AJNR Am J Neuroradiol 1993;14:583–586

   FREE Full Text
5. ↵
   Ng SH, Wan YL, Wong HF, et al. Preoperative embolization of meningiomas: comparison of superselective and subselective techniques. J Formos Med Assoc 1998;97:153–158

   PubMed
6. ↵
   Latchaw RE, Gold LH. Polyvinyl foam embolization of vascular and neoplastic lesions of the head, neck, and spine. Radiology 1979;131:669–679

   CrossRefPubMedWeb of Science
7. Berenstein A, Kricheff II. Microembolization techniques of vascular occlusion: radiologic, pathologic, and clinical correlation. AJNR Am J Neuroradiol 1981;2:261–267

   Abstract/FREE Full Text
8. Bendszus M, Klein R, Burger R, et al. Efficacy of trisacryl gelatin microspheres versus polyvinyl alcohol particles in the preoperative embolization of meningiomas. AJNR Am J Neuroradiol 2000;21:255–261

   Abstract/FREE Full Text
9. ↵
   Wakhloo AK, Juengling FD, Van Velthoven V, et al. Extended preoperative polyvinyl alcohol microembolization of intracranial meningiomas: assessment of two embolization techniques. AJNR Am J Neuroradiol 1993;14:571–582

   Abstract/FREE Full Text
10. ↵
    Jungreis CA. Skull-base tumors: ethanol embolization of the cavernous carotid artery. Radiology 1991;181:741–743

    PubMedWeb of Science
11. ↵
    Cook GJ, Fogelman I, Reidy JF. Successful repeat transcatheter ablation of a mediastinal parathyroid adenoma 6 years after alcohol embolization. Cardiovasc Intervent Radiol 1997;20:314–316

    CrossRefPubMedWeb of Science
12. Doppman JL, Brown EM, Brennan MF, et al. Angiographic ablation of parathyroid adenomas. Radiology 1979;130:577–582

    CrossRefPubMed
13. Geelhoed GW, Krudy AG, Doppman JL. Long-term follow-up of patients with hyperparathyroidism treated by transcatheter staining with contrast agent. Surgery 1983;94:849–862

    PubMedWeb of Science
14. ↵
    Miller DL, Doppman JL, Chang R, et al. Angiographic ablation of parathyroid adenomas: lessons from a 10-year experience. Radiology 1987;165:601–607

    PubMedWeb of Science
15. ↵
    Shapiro L, Dinarello CA. Hyperosmotic stress as a stimulant for proinflammatory cytokine production. Exp Cell Res 1997;231:354–362

    CrossRefPubMedWeb of Science
16. ↵
    Berl T, Siriwardana G, Ao L, et al. Multiple mitogen-activated protein kinases are regulated by hyperosmolality in mouse IMCD cells. Am J Physiol 1997;272:F305–F311
17. ↵
    Galcheva-Gargova Z, Derijard B, Wu IH, Davis RJ. An osmosensing signal transduction pathway in mammalian cells. Science 1994;265:806–808

    Abstract/FREE Full Text
18. ↵
    Hartwell RC, Sutton LN. Mannitol, intracranial pressure, and vasogenic edema. Neurosurgery 1993;32:444–450; discussion 450

    PubMed
19. ↵
    James HE. Methodology for the control of intracranial pressure with hypertonic mannitol. Acta Neurochir (Wien) 1980;51:161–172

    CrossRefPubMed
20. ↵
    Uenohara H, Imaizumi S, Suzuki J, Yoshimoto T. The protective effect of mannitol, vitamin E and glucocorticoid on ischaemic brain injury: evaluation by chemiluminescence, energy metabolism and water content. Neurol Res 1988;10:73–80

    PubMed
21. ↵
    Malek AM, Goss GG, Jiang L, et al. Mannitol at clinical concentrations activates multiple signaling pathways and induces apoptosis in endothelial cells. Stroke 1998;29:2631–2640

    Abstract/FREE Full Text
22. ↵
    Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia 2002;4:465–473

    CrossRefPubMedWeb of Science
23. Gando S. Disseminated intravascular coagulation in trauma patients. Semin Thromb Hemost 2001;27:585–592

    CrossRefPubMedWeb of Science
24. Blann AD. Endothelial cell activation, injury, damage and dysfunction: separate entities or mutual terms? Blood Coagul Fibrinolysis 2000;11:623–630

    CrossRefPubMedWeb of Science
25. Spaet TH, Gaynor E. Vascular endothelial damage and thrombosis. Adv Cardiol 1970;4:47–66

    PubMed
26. ↵
    Pearson JD. Endothelial cell function and thrombosis. Baillieres Best Pract Res Clin Haematol 1999;12:329–341

    CrossRefPubMed
27. ↵
    Schmidt AM, Hori O, Chen JX, et al. Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 1995;96:1395–1403
28. ↵
    Nagy Z, Pappius HM, Mathieson G, Huttner I. Opening of tight junctions in cerebral endothelium. I. Effect of hyperosmolar mannitol infused through the internal carotid artery. J Comp Neurol 1979;185:569–578

    CrossRefPubMed
29. ↵
    Neuwelt EA, Hill SA, Frenkel EP. Osmotic blood-brain barrier modification and combination chemotherapy: concurrent tumor regression in areas of barrier opening and progression in brain regions distant to barrier opening. Neurosurgery 1984;15:362–366

    PubMedWeb of Science
30. Neuwelt EA, Frenkel EP, Diehl JT, et al. Osmotic blood-brain barrier disruption: a new means of increasing chemotherapeutic agent delivery. Trans Am Neurol Assoc 1979;104:256–260

    PubMed
31. ↵
    Heimberger K, Samec P, Binder H, et al. Blood brain barrier modification and chemotherapy. Interventional neuroradiology in the treatment of malignant gliomas. Acta Radiol Suppl 1986;369:223–226

    PubMed
32. ↵
    Vallet B, Wiel E. Endothelial cell dysfunction and coagulation. Crit Care Med 2001;29:S36–S41

    CrossRefPubMedWeb of Science